MY185464A - Complement component c5 irna compositions and methods of use thereof - Google Patents
Complement component c5 irna compositions and methods of use thereofInfo
- Publication number
- MY185464A MY185464A MYPI2015002325A MYPI2015002325A MY185464A MY 185464 A MY185464 A MY 185464A MY PI2015002325 A MYPI2015002325 A MY PI2015002325A MY PI2015002325 A MYPI2015002325 A MY PI2015002325A MY 185464 A MY185464 A MY 185464A
- Authority
- MY
- Malaysia
- Prior art keywords
- complement component
- methods
- irna
- compositions
- irna compositions
- Prior art date
Links
Abstract
The invention relates to iRNA, e.g., double-stranded ribonucleic acid (dsRNA), compositions targeting the complement component C5 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of C5 and to treat subjects having a complement component C5-associated disease, e.g., paroxysmal nocturnal hemoglobinuria.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361782531P | 2013-03-14 | 2013-03-14 | |
US201361837399P | 2013-06-20 | 2013-06-20 | |
US201361904579P | 2013-11-15 | 2013-11-15 | |
PCT/US2014/025882 WO2014160129A2 (en) | 2013-03-14 | 2014-03-13 | Complement component c5 irna compositions and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MY185464A true MY185464A (en) | 2021-05-19 |
Family
ID=87846572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2015002325A MY185464A (en) | 2013-03-14 | 2014-03-13 | Complement component c5 irna compositions and methods of use thereof |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY185464A (en) |
-
2014
- 2014-03-13 MY MYPI2015002325A patent/MY185464A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019008380A (en) | Complement component c5 irna compositions and methods of use thereof. | |
MX2021006052A (en) | Complement component irna compositions and methods of use thereof. | |
WO2016201301A8 (en) | Complement component c5 irna compositions and methods of use thereof | |
MX2019006413A (en) | Serpinc1 irna compositions and methods of use thereof. | |
MX2018006989A (en) | Methods and compositions for treating a serpinc1-associated disorder. | |
WO2017019660A8 (en) | Xanthine dehydrogenase (xdh) irna compositions and methods of use thereof | |
PH12017500669A1 (en) | Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression | |
MX2021000656A (en) | SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF. | |
MX2019012252A (en) | Compositions and methods for inhibiting expression of the alas1 gene. | |
MY181888A (en) | Tmprss6 irna compositions and methods of use thereof | |
MX2021010716A (en) | Compositions and methods for inhibiting expression of the lect2 gene. | |
MX2022001017A (en) | Compositions and methods for inhibiting expression of the alas1 gene. | |
MY185464A (en) | Complement component c5 irna compositions and methods of use thereof | |
IN2015DN02699A (en) | ||
AR127877A2 (en) | RNAi COMPOSITIONS OF COMPLEMENT C5 COMPONENT AND METHODS FOR ITS USE | |
EA037110B9 (en) | PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF |